Design, synthesis, and pharmacological evaluation of multitarget-directed ligands with both serotonergic subtype 4 receptor (5-HT4R) partial agonist and 5-HT6R antagonist activities, as potential treatment of Alzheimer's disease

Design, synthesis, and pharmacological evaluation of multitarget-directed ligands with both serotonergic subtype 4 receptor (5-HT4R) partial agonist and 5-HT6R antagonist activities, as potential treatment of Alzheimer's disease

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: European Journal of Medicinal Chemistry - Volume 121, 4 October 2016, Pages 283-293

Samir Yahiaoui, Katia Hamidouche, Céline Ballandonne, Audrey Davis, Jana Sopkova de Oliveira Santos, Thomas Freret, Michel Boulouard, Christophe Rochais, Patrick Dallemagne,